We have shown that ubiquitous, beta-actin promoter-driven SRG3 (SRG3β-actin) overexpression in transgenic mice protects against experimental autoimmune encephalomyelitis (EAE) [17]. This evidence concerns the gene SMARCC1 and experimental autoimmune encephalomyelitis.